Therefore, the identification of asporin as a negative regulator of aggrecan and type Π collagen, as well as the elucidation of the mechanisms by which it is induced in human nucleus pulposus cells, may provide potential immune-based anti-disc degeneration therapies by targeting asporin expression. The gene discussed is ACAN; the disease is intervertebral disk degenerative disorder.